Cardiac, vitamin drugs see pharma sales rebound with 4.5% growth in Sept

Industry says fresh prescriptions are picking up

The domestic pharma market has come back strong in September by clocking a 4.5 per cent growth riding on sales of cardiac, anti-diabetic and vitamins. 

In August the market had clocked a negative growth of 2.2 per cent, while the July growth was almost flat at 0.2 per cent. In fact, barring June (which saw the market grow by 2.4 per cent), the domestic pharma market has been in negative terrain since the beginning of this fiscal.March had seen a 9 per cent growth thanks to panic-buying of chronic medicines. 

Cardiac and diabetic medicines have been the bellwether for pharma